CHRS vs WYNN · rev $26.6M vs P/E 29, rev $3.71B
Coherus BioSciences Inc (CHRS) versus Wynn Resorts Limited (WYNN) — a side-by-side from cached financials, not a winner call.
Coherus BioSciences Inc (CHRS) is a biotechnology company listed on US.
Wynn Resorts Limited (WYNN) is a resorts & casinos company listed on NASDAQ.
Latest reported CHRS revenue for 2026-06-30 was $26.6M. Net income was -$59.0M. CHRS currently screens at market cap $223.7M.
Latest reported WYNN revenue for 2026-06-30 was $3.71B. Net income was $260.5M. WYNN currently screens at market cap $10.62B and trailing P/E 29.3.
CHRS currently screens at market cap $223.7M. WYNN currently screens at market cap $10.62B and trailing P/E 29.3.
Not investment advice. Open the CHRS and WYNN stock pages for the full models.
Not investment advice.